Search

everythinglearnresearchcommunity

for

Search:↓

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Certain drugs that block specific enzymes can help treat prostate diseases.

New steroid compounds effectively inhibit 5α-reductase and may treat hair loss.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

Researchers made two new compounds that could be used for medicine.

A new method was developed to make a compound used in finasteride and epristeride with a 69% yield.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

A new compound was made that might help treat diseases related to male hormones.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

Hormone levels change during puberty, leading to physical developments like pubic hair and voice changes.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

17α-estradiol lotion can reduce hair loss but doesn't promote new hair growth.

A boy with severe Vitamin D-resistant rickets did not respond to treatment and lacked a common symptom, suggesting a need for alternative treatments.

A genetic defect causes males in some Mediterranean populations to be born with ambiguous genitalia and develop male traits at puberty.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Hair lotions with 17 alpha-estradiol can reduce hair loss but won't regrow new hair.

17-β-Estradiol applied to the skin stops hair growth, while ICI 182 780 helps hair grow in mice.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

17-β estradiol and prednisolone may speed up hair regrowth after chemotherapy.

Measuring 17-hydroxyprogesterone in hair can help monitor androgen levels in people with congenital adrenal hyperplasia.

Laser treatment improves hair density and increases growth factors in androgenetic alopecia.

Scalp hair 17-OHP and androstenedione levels can help monitor treatment in CAH patients.

A young woman's symptoms suggested PCOS, but tests and surgery confirmed and treated a rare ovarian tumor, resolving her condition.

Spironolactone treatment reduced hair growth and androgen levels in hirsute women, but the overall effectiveness was just adequate.